ELSE NUTRITION HLDGS INC - BABYF STOCK NEWS

Else Nutrition Holdings has announced a significant expansion of its product availability, with the award-winning Baby Super Cereal and Toddler Organic products now sold at over 7,000 locations of the largest pharmacy chain in the U.S. This move follows the initial launch of the Toddler Organic line in 1,040 locations in September 2022. Else Baby Super Cereal is recognized as the top-selling baby cereal on Amazon and is the first Clean Label Purity Award-certified baby cereal in the U.S. The products are crafted from whole-plant ingredients, catering to children with dietary restrictions. CEO Hamutal Yitzhak emphasized that this partnership greatly enhances product accessibility and aligns with Else's mission of providing nutritious, plant-based options for children.

Else Nutrition Holdings Inc. (BABYF) has expanded its distribution network in Canada, launching Toddler and Kids Shake products in over 440 stores across the country as of March 2023. This partnership with Canada's largest food distributor is expected to boost customer access and drive substantial growth for the brand. The CEO, Hamutal Yitzhak, emphasized the importance of this step as it enables the company to reach health-conscious parents nationwide, aspiring to become a household name in Canada. Else Nutrition is focused on providing innovative, plant-based nutrition alternatives for children and has achieved notable success, including being a top seller on platforms like Amazon.

Else Nutrition Holdings Inc. (BABYF) announces the addition of Baby Super Cereal to Walmart's product range, marking its first entry into retail stores. This clean label certified baby cereal will be available in Original and Vanilla flavors across approximately 500 Walmart locations. The company has enjoyed increasing demand for Super Cereal since it became a best-seller on Amazon.com in Q3 2022. CEO Hamutal Yitzhak emphasized the importance of this partnership in expanding access to their minimally processed, plant-based nutrition products for families in the U.S.

Else Nutrition Holdings Inc reported its fourth quarter and fiscal year 2022 financial results, achieving $2.4M in revenues for 4Q22, an 86% increase from 4Q21. The company faced product shortages due to a mechanical malfunction, estimated to have caused a revenue loss of $1.1M in the quarter. For FY2022, revenues reached $8.6M, up 82% from FY2021. Else expanded its market presence, listing products in over 11,000 stores in North America and entering Canada and China. The company plans to double its product SKUs in 2023 and focuses on FDA approval for its infant formula, with hopes to capture a share of the $33 billion Chinese market.

Else Nutrition Holdings Inc (ticker: BABYF) announced that it will report its fourth quarter and fiscal year 2022 financial results on March 31, 2023. A conference call will be held at 10 a.m. ET on the same day to discuss these results. Else Nutrition specializes in plant-based nutrition for infants and children, emphasizing clean ingredients free from dairy and soy. The company has received accolades, including being ranked the #1 seller in its category on Amazon. Interested parties can access the call through an online webcast.

Else Nutrition Holdings Inc. has expanded its retail presence significantly, now stocking products in over 11,000 stores across North America, a tenfold increase from 1,200 locations at the start of 2022. This expansion includes entry into Canadian markets, with products available at national retailers. The company's distribution points have also surged to more than 25,000. CEO Hamutal Yitzhak expressed optimism about the company becoming a national brand, indicating strong consumer demand and brand equity. Else is recognized for its clean, plant-based nutrition products for young children and has received numerous awards for its offerings.

Else Nutrition Holdings Inc. has announced the opening of a second powder production facility in the US and the start of manufacturing in Europe, more than tripling its production capacity. This expansion aims to meet increasing retail demand and resolve past out-of-stock issues, as the company has conducted multiple production campaigns in early 2023. With plans for continued accelerated production throughout the year, Else seeks to stabilize its inventory levels to support growth and fulfill robust customer demands. CEO Hamutal Yitzhak emphasized the importance of these facilities for future success in the expanding market.

Else Nutrition Holdings Inc. (BABYF) announced the approval of its infant growth study protocol by the Institutional Review Board (IRB), marking a significant milestone in the development of its plant-based infant formula. This approval, following the ethical committee's initial endorsement, is crucial for assessing the formula's effectiveness and safety for infants as it aims to provide a dairy-free alternative. CEO Hamutal Yitzhak expressed pride in this achievement, highlighting the company’s commitment to delivering high-quality nutrition solutions.